← Back to Search
Systemic Bioavailability Of Penclomedine (NSC-338720) From Oil-in-water Emulsions Administered Intraduodenally To Rats
R. A. Myers, V. Stella
Published 1992 · Chemistry
Download PDFAnalyze on Scholarcy
Abstract Penclomedine (NSC-338720) is a low melting point, poorly water-soluble cytotoxic agent with good solubility in triglycerides and a high octanol/water partition coefficient. Its pharmacokinetics in anesthetized rats was studied after i.v. bolus injection of a soybean oil emulsion. Penclomedine displayed biexponential behavior with an apparent t 1 2 (± SE ) of 1.9 ± 0.3 h and a clearance of 3.3 ± 0.1 ml/min per kg. After intraduodenal administration to anesthetized rats as either a 10% o/w emulsion of tributyrin, trioctanoin, triolein, soybean oil or mineral oil, or as a suspension, the rank order of absolute bioavailability was trioctanoin > soybean oil ≈ triolein > mineral oil > tributyrin > suspension. The results were rationalized by assuming that drug release from the emulsions was by a combination of vehicle metabolism and diffusional drug release. The poor bioavailability from tributyrin was rationalized by the rapid release of penclomedine resulting in its possible precipitation and subsequent need to redissolve.
This paper references
Physicochemical basis of increased bioavailability of a poorly water-soluble drug following oral administration as organic solutions.
A. T. Serajuddin (1988)
Comparative effects of cholic, chenodeoxycholic, and ursodeoxycholic acids on micellar solubilization and intestinal absorption of cholesterol.
M. Reynier (1981)
Absorption, metabolism and excretion of drugs.
M. Milne (1966)
Effect of Oleic Acid Vesicles on Intestinal Absorption of Carboxyfluorescein in Rats
M. Murakami (2004)
Drug management of hypercholesterolemia.
B. L. Martz (1979)
ABSORPTION AND DISSOLUTION STUDIES ON DIPHENYLHYDANTOIN CAPSULES
K. Arnold (1970)
Coassimilation of dietary fat and benzo(a)pyrene in the small intestine: an absorption model using the killifish.
R. Vetter (1985)
Aqueous solubilisation of vitamin D3 in normal man.
M. Rautureau (1981)
Solubilization of diazepam in bile salts and in sodium cholate-lecithin-water phases
M. Rosoff (1980)
Modification of Intestinal Absorption of Drugs by Lipoidal Adjuvants
S. Muranishi (2004)
Absorption of medium and long chain triglycerides: factors influencing their hydrolysis and transport.
N. Greenberger (1966)
Enhancement of bioavailability of a hydrophobic amine antimalarial by formulation with oleic acid in a soft gelatin capsule.
Vittorio Stella (1978)
Biometry: The Principles and Practice of Statistics in Biological Research
R. R. Sokal (1969)
Enhancement of the bioavailability of propranolol and metoprolol by food
A. Melander (1977)
Effect of a nonabsorbable lipid, sucrose polyester, on the absorption of DDT by the rat
R. A. Volpenhein (1980)
Absorption, distribution, metabolism, and excretion of griseofulvin in man and animals.
C. Lin (1975)
The oral absorption of cefoxitin from oil and emulsion vehicles in rats
K. Palin (1986)
Pancreatic Lipase-Catalyzed Hydrolysis of Esters of Hydroxymethyl Phenytoin Dissolved in Various Metabolizable Vehicles, Dispersed in Micellar Systems, and in Aqueous Suspensions
F. J. Álvarez (2004)
Biopharmaceutical studies of lipid-containing oral dosage forms: Relationship between drug absorption rate and digestibility of vehicles
Yamahira Yoshiya (1979)
Increasing Intestinal Absorption of Drugs by Formulation
F. Kincl (1986)
Observations on temperature distribution and liver blood flow in the rat
J. Birnie (1952)
Kinetics of diphenylhydantoin disposition in man.
T. Suzuki (1970)
Some generalizations of the T-method in simultaneous inference
Y. Hochberg (1974)
EVALUATION OF LIPID-CONTAINING ORAL DOSAGE FORMS IN RATS
Y. Yamahira (1979)
Systemic availability of o,p'-DDD in normal dogs, fasted and fed, and in dogs with hyperadrenocorticism.
A. Watson (1987)
Mineral oil in the diet enhances fecal excretion of DDT in the rhesus monkey.
K. Rozman (1983)
Low-melting phenytoin prodrugs as alternative oral delivery modes for phenytoin: a model for other high-melting sparingly water-soluble drugs.
Y. Yamaoka (1983)
Bioavailability of phenytoin from oil suspension and emulsion in dogs
Shinkuma Denji (1981)
Increasing oral bioavailability of progesterone by formulation.
F. Kincl (1978)
Particle size of drugs and its relationship to absorption and activity.
J. Fincher (1968)
This paper is referenced by
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
C. H. Porter (2007)
A review on self-emulsified drug delivery system
P. Thakare (2016)
Enhancing intestinal drug solubilisation using lipid-based delivery systems.
C. H. Porter (2008)
Improvement of Bioavailability for Lovastatin using Self-microemulsifying Drug Delivery System
Bok-Young Yoon (2002)
Emulsions in Health Care Applications—An Overview
G. Marti-Mestres (2002)
An in vitro release kinetic examination and comparative evaluation between submicron emulsion and polylactic acid nanocapsules of clofibride.
N. Magalhães (1995)
Prevention of topical and ocular oxidative stress by positively charged submicron emulsion.
S. Benita (1999)
Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine
Shui-Mei Khoo (1998)
Oral lipid-based formulations.
D. Hauss (2007)
A REVIEW ON SELF MICRO EMULSIFYING DRUG DELIVERY SYSTEM: AN APPROACH TO E NHANCE THE ORAL BIOAVAILABILITY OF POORLY WATER SOLUBLE DRUGS
S. Prachi (2012)
BIOAVAILABILITY OF DIACYLGLYCEROL MICROEMULSION
Y. Chen (2013)
Quantitative Solubility Relationships and the Effect of Water Uptake in Triglyceride/Monoglyceride Microemulsions
S. S. Rane (2007)
Physicochemical Characterization and Acute Toxicity Evaluation of a Positively‐charged Submicron Emulsion Vehicle
S. Klang (1994)
Oral Bioavailability of Flutamide from 1‐O‐Alkylglycerol Stabilized o/w Nanoemulsions
B. Madhusudhan (2007)
Effect of Oil-in-Water Submicron Emulsion Surface Charge on Oral Absorption of a Poorly Water-Soluble Drug in Rats
S. Poullain-Termeau (2008)
Administration of Emulsions to the Gastrointestinal Tract
D. Craig (2000)
Formulation and Intestinal Absorption Enhancement Evaluation of Water-in-Oil Microemulsions Incorporating Medium-Chain Glycerides
P. Constantinides (2004)
Gastric pre-processing is an important determinant of the ability of medium-chain lipid solution formulations to enhance oral bioavailability in rats.
K. W. Y. Lee (2013)
Bioavailability of seocalcitol I: Relating solubility in biorelevant media with oral bioavailability in rats--effect of medium and long chain triglycerides.
M. Grove (2005)
Development and bioavailability assessment of ramipril nanoemulsion formulation.
S. Shafiq (2007)
Approaches for the development of solid self-emulsifying drug delivery systems and dosage forms
Suman Katteboina (2009)
Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis.
L. Sek (2001)
Enhanced intestinal absorption of an RGD peptide from water-in-oil microemulsions of different composition and particle size
P. Constantinides (1995)
Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine.
C. H. Porter (2004)
Development of positively charged colloidal drug carriers: Chitosan-coated polyester nanocapsules and submicron-emulsions
P. Calvo (1997)
Self nano-emulsifying simvastatin based tablets: design and in vitro/in vivo evaluation
G. Abdelbary (2013)
Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility.
P. C. de Smidt (2004)
Enhanced oral bioavailability of daidzein by self-microemulsifying drug delivery system.
Q. Shen (2010)
Lipids in oral controlled release drug delivery
B. Boyd (2011)
Lipid Microemulsions for Improving Drug Dissolution and Oral Absorption: Physical and Biopharmaceutical Aspects
P. Constantinides (2004)
Bioavailability of cyclosporine in rats after intragastric administration: a comparative study of the L2-phase and two other lipid-based vehicles.
M. Bojrup (1996)
years of oral lipid-based formulations : Provenance , progress and future perspectives ☆
O. Feeney (2016)See more